Analisis Kinerja Keuangan dan Pergerakan Saham Emiten Farmasi di BEI Sebelum dan Saat COVID 19
Keywords:
Capital Market, Financial, Pharmaceutical, Wilcoxon, Interest, Investors, Stocks, ProfitAbstract
This article is written to present appropriate facts and data so that they can refute or justify these
assumptions, regarding the capital market, investors after knowing whether the assumptions are valid or
invalid they need to determine their attitude, whether to sell, buy or just wait and see. is quantitative
research. Sources of data in this study using secondary data. The secondary data used in this study is the
financial statements of each pharmaceutical sub-sector company in 2018, 2019, 2020. The data collection
technique used in this study is the documentation method. The data analysis technique for financial
performance used is the Wilcoxon Sign Test asymp value. there is no strong interest from investors and
potential investors to make long-term sales or purchases, all are still waiting and see and these stocks
are mostly open and close at prices that are not too high or low because many buy or sell in the short
term to get profits or just beautify your portfolio with the expectation of future profit
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Dagna Puspabhita, Harsita Gianti, Muhammad Budi Nur Iman
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of the work published in this journal and grant first publication rights to the journal. Authors may make separate, additional contractual arrangements for non-exclusive distribution of the journal-published version of the work (e.g., posting it to an institutional repository or publishing it in a book) with acknowledgment of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) before and during the submission process, as it can result in productive exchanges, as well as earlier and greater citation of the published work.
Use of published articles will be governed by the Creative Commons Attribution license as currently displayed at Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).